Pregled bibliografske jedinice broj: 179496
Supplementation with antioxidants in the treatment of Graves' disease ; the effect on glutathione peroxidase activity and concentration of selenium
Supplementation with antioxidants in the treatment of Graves' disease ; the effect on glutathione peroxidase activity and concentration of selenium // Clinica chimica acta, 341 (2004), 55-63 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 179496 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Supplementation with antioxidants in the treatment of Graves' disease ; the effect on glutathione peroxidase activity and concentration of selenium
Autori
Bačić Vrca, Vesna ; Škreb, Franjo ; Čepelak, Ivana ; Romić, Željko ; Mayer, Ljiljana
Izvornik
Clinica chimica acta (0009-8981) 341
(2004);
55-63
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Graves' disease; Antioxidants; Selenium; Glutathione peroxidase
Sažetak
The effect of supplementation with a fixed combination of antioxidants (vitamins C and E, beta-carotene and selenium) was monitored on the speed of attaining euthyroidism in a group of patients with Graves' disease, treated with methimazole. Methods: The activity of glutathione peroxidase in whole blood and the concentrations of selenium, pituitary and thyroid hormones in serum were measured, prior to commencement of therapy and after 30 and 60 days. Results: Patients who received supplementation with antioxidants in addition to therapy with methimazole (Group A, n = 29), attained euthyroidism faster than the patients treated with only methimazole (Group B, n = 28). The concentration of selenium in the serum of patients in Group A increased significantly during treatment (p<0.001), while there was no statistically significant change in the patients in Group B. The concentration of selenium in the serum between the groups differed statistically significantly 30 days (p<0.05) and 60 days (p<0.01) after the commencement of therapy. Activity of glutathione peroxidase in whole blood increased during treatment in both groups of patients. However, a statistically more significant increase occurred in Group A compared to Group A compared to Group B, 30 days after the commencement of therapy (p<0.01). Conclusion: The results of the study clearly indicate that supplementation with antioxidants in the treatment of Graves´ disease is justified, particularly those containing selenium.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
0006631
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Profili:
Franjo Škreb
(autor)
Željko Romić
(autor)
Ivana Čepelak
(autor)
Vesna Bačić Vrca
(autor)
Ljiljana Mayer
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE